Records 1 - 4
| Genetic variations in the CXCR5 gene decrease the risk of clinical relapse after discontinuation of nucleos(t)ide analogue therapy in patients with chronic hepatitis B.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2019 Nov 78 104124.
Wu Yin, Fan Jiaojiao, Liao Guichan, Xia Muye, Jiang Deke, Peng Jie, Zhang Xiaoyong, Liu Hongy
| Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B.
PloS one 2018 13 (7): e0199094.
Kim Tae Hyung, Lee Eun-Ju, Choi Ji-Hye, Yim Sun Young, Lee Sunwon, Kang Jaewoo, Lee Yoo Ra, Lee Han Ah, Choi Hyuk Soon, Kim Eun Sun, Keum Bora, Seo Yeon Seok, Yim Hyung Joon, Jeen Yoon Tae, Chun Hoon Jai, Lee Hong Sik, Kim Chang Duck, Woo Hyun Goo, Um Soon
| Genetic variant in CXCL13 gene is associated with susceptibility to intrauterine infection of hepatitis B virus.
Scientific reports 2016 05 6 26465.
Wan Zhihua, Lin Xiaofang, Li Tongyang, Zhou Aifen, Yang Mei, Hu Dan, Feng Li, Peng Songxu, Fan Linlin, Tu Si, Bin Zhang , Du Yuk
| Genetic polymorphisms of CXCR5 and CXCL13 are associated with non-responsiveness to the hepatitis B vaccine.
Vaccine 2014 Sep 32 (41): 5316-22.
Duan Zhaojun, Chen Xiangmei, Liang Zhenglun, Zeng Ying, Zhu Fengcai, Long Lu, McCrae Malcolm A, Zhuang Hui, Shen Tao, Lu Fengm